MTOR and neoplasm: The mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase that turns into complexes with other molecules in tumor cells, including mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), and both of them can affect the function of immune cells and promote the growth of tumor cells (17).